When it comes to oversight, what is the AMA’s stance on artificial intelligence (AI)?
The AMA advocates for a collaborative, cross-sector approach to AI governance, emphasizing the need for both government and non-government entities to participate in the development and regulation of AI technologies. This holistic governance approach ensures that risks associated with AI, such as data misuse or biased algorithms, are managed proactively. By fostering this collaboration, the AMA envisions a future where AI development is closely monitored but flexible enough to allow for innovation, addressing both safety concerns and opportunities for improved patient outcomes.
This question was answered in our Coding Essentials for Infusion & Injection Therapy Services. For more hot topics relating to infusion services, please visit our store or call us at 1.800.252.1578, ext. 2.
CPT® copyright 2025 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Unlock 50% off all 2024 edition books when you order by July 5! Use the coupon code CO5024 at checkout to claim this offer!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24